AMARIN CORP PLC\UK Inventory, Noncurrent
AMARIN CORP PLC\UK (AMRN) had Inventory, Noncurrent of $0 as of 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:InventoryNoncurrent · last filed 2026-03-02
- 2025-12-31: Inventory, Noncurrent $0.00.
- 2025-09-30: Inventory, Noncurrent $9.11M.
- 2025-06-30: Inventory, Noncurrent $39.59M.
- 2025-03-31: Inventory, Noncurrent $57.40M.
| Period end | Inventory, Noncurrent |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-02 |
| 2025-09-30 | $9.11M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $39.59M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $57.40M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $64.74M 10-K · filed 2026-03-02 |
| 2024-09-30 | $74.02M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $71.29M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $74.22M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $77.61M 10-K · filed 2025-03-12 |
| 2023-09-30 | $91.79M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $122.32M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $143.73M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $163.62M 10-K · filed 2024-02-29 |
| 2022-09-30 | $187.96M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $210.25M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $141.05M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $121.25M 10-K · filed 2023-03-01 |
| 2014-12-31 | $0.00 10-K · filed 2015-03-03 |
| 2013-12-31 | $5.48M 10-K · filed 2015-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |